Today's Most Popular
Screening for Prostate Cancer — The Controversy That Refuses to Die
Article posted from 
New England Journal of Medicine (http://search.nejm.com/search?p=R&srid=S9%2d2&lbc=nejm&w=men%27s%20health&url=http%3a%2f%2fcontent%2enejm%2eorg%2fcgi%2fcontent%2fshort%2f360%2f13%2f1351&rk=4&uid=858524135&sid=2&ts=rss&rsc=92vMKmg1MJoisF8Y&method=and&isort=score&start%5fyear=1998)
New England Journal of Medicine (http://search.nejm.com/search?p=R&srid=S9%2d2&lbc=nejm&w=men%27s%20health&url=http%3a%2f%2fcontent%2enejm%2eorg%2fcgi%2fcontent%2fshort%2f360%2f13%2f1351&rk=4&uid=858524135&sid=2&ts=rss&rsc=92vMKmg1MJoisF8Y&method=and&isort=score&start%5fyear=1998)
In the United States, most men over the age of 50 years have had a prostate-specific-antigen (PSA) test, 1 despite the absence of evidence from large, randomized trials of a net benefit. Moreover, about 95% of male urologists and 78% of primary care physicians who are 50 years of age or older report…
More Stories in New England Journal of Medicine
- Chronic Prostatitis
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- Controversies in the Treatment of Prostate Cancer
- Management of Prostate Cancer
- Screening for Prostate Cancer — The Controversy That Refuses to Die
Other Feedables
Tech Sale Feeds - A bargain buffet
Marketing Feeds - A full plate of branding.
Stock Tips - Feeding your piggy bank.
Google - All Google News- Auto Feeds - The auto news drive thru.
- more Feedables...